{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:41:50Z","timestamp":1761860510160,"version":"build-2065373602"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK067269","R01DK128129"],"award-info":[{"award-number":["R01 DK067269","R01DK128129"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopedic Clinics of North America"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ocl.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T17:58:59Z","timestamp":1679594339000},"page":"327-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update on Medical Management of Diabetes"],"prefix":"10.1016","volume":"54","author":[{"given":"Dilasha","family":"Katwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Dagogo-Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/dc21-2396","article-title":"2022 National standards for diabetes self-management education and support","volume":"45","author":"Davis","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib4","first-page":"S17","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes- 2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"23","key":"10.1016\/j.ocl.2023.02.005_bib5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ocl.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ocl.2023.02.005_bib7","first-page":"549","article-title":"Preventing diabetes-related morbidity and mortality in the primary care setting","volume":"94","author":"Dagogo-Jack","year":"2002","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib8","first-page":"S4","article-title":"Summary of revisions: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.2337\/dc22-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2022.","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib10","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.2337\/dc22-S011","article-title":"11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib11","first-page":"S144","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ocl.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic Costs of Diabetes in the U.S. in 2017","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.ocl.2023.02.005_bib13","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case- fatality among 3.25 Million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ocl.2023.02.005_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.dsx.2015.04.002","article-title":"The diabetic foot","volume":"10","author":"Ahmad","year":"2016","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.ocl.2023.02.005_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198703053161007","article-title":"Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications","volume":"316","author":"Greene","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1751-7176.2011.00434.x","article-title":"Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection","volume":"13","author":"Long","year":"2011","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.ocl.2023.02.005_bib19","first-page":"20","article-title":"Primary prevention of cardiovascular disease in diabetic patients","volume":"12","author":"Dagogo-Jack","year":"2006","journal-title":"Cardio Q"},{"issue":"12","key":"10.1016\/j.ocl.2023.02.005_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/1535370216654227","article-title":"Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications","volume":"241","author":"Brannick","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.ocl.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ecl.2017.10.001","article-title":"Prediabetes and cardiovascular disease: pathophysiology and interventionsfor prevention and risk reduction","volume":"47","author":"Brannick","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ocl.2023.02.005_bib23","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2\u20134","key":"10.1016\/j.ocl.2023.02.005_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.semvascsurg.2019.02.001","article-title":"The diabetic foot: Pathophysiology, evaluation, and treatment","volume":"31","author":"Bandyk","year":"2018","journal-title":"Semin Vasc Surg"},{"issue":"8","key":"10.1016\/j.ocl.2023.02.005_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2337\/diacare.22.8.1354","article-title":"Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ocl.2023.02.005_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1938640017694722","article-title":"Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death","volume":"11","author":"Wukich","year":"2018","journal-title":"Foot Ankle Spec"},{"issue":"16","key":"10.1016\/j.ocl.2023.02.005_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.114.010815","article-title":"Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage","volume":"130","author":"Selvin","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ocl.2023.02.005_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000285280","article-title":"Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk","volume":"19","author":"Dagogo-Jack","year":"2010","journal-title":"Med Princ Pract"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib29","first-page":"129","article-title":"Metabolic syndrome, prediabetes and the science of primary prevention","volume":"36","author":"Nyenwe","year":"2011","journal-title":"Minerva Endocrinol"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ocl.2023.02.005_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ocl.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib34","first-page":"S38","article-title":"4. Lifestyle management: standards of medical care in diabetes- 2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ocl.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc16-1728","article-title":"Physical activity\/ exercise and diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ocl.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1249\/01.MSS.0000074459.41029.75","article-title":"Daily weight-bearing activity does not increase the risk of diabetic foot ulcers","volume":"35","author":"Lemaster","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"Suppl 3","key":"10.1016\/j.ocl.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0021-9150(00)00664-X","article-title":"Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in type 2 diabetes","volume":"156","author":"Kong","year":"2001","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jdi.12952","article-title":"Review of the role of cigarette smoking in diabetic foot","volume":"10","author":"Xia","year":"2019","journal-title":"J\u00a0Diabetes Investig"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.ocl.2023.02.005_bib42","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology task force on clinical expert consensus documents","volume":"72","author":"Barua","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ocl.2023.02.005_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/M15-2023","article-title":"Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.ocl.2023.02.005_bib44","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2012.13043","article-title":"Strategies to help a smoker who is struggling to quit","volume":"308","author":"Rigotti","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib45","doi-asserted-by":"crossref","first-page":"108101","DOI":"10.1016\/j.jdiacomp.2021.108101","article-title":"DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases","volume":"36","author":"Handelsman","year":"2022","journal-title":"J\u00a0Diabetes Complications"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib46","first-page":"S73","article-title":"6. Glycemic targets: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.ocl.2023.02.005_bib47","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ocl.2023.02.005_bib48","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ocl.2023.02.005_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"9131","key":"10.1016\/j.ocl.2023.02.005_bib50","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/dom.12610","article-title":"Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas","volume":"18","author":"Deacon","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"9493","key":"10.1016\/j.ocl.2023.02.005_bib52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"issue":"9681","key":"10.1016\/j.ocl.2023.02.005_bib53","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ocl.2023.02.005_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2016.02.146","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on heart failure: a meta-analysis of randomized clinical trials","volume":"211","author":"Kongwatcharapong","year":"2016","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/dom.12456","article-title":"Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer","volume":"17","author":"Abdelmoneim","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ocl.2023.02.005_bib56","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"issue":"19","key":"10.1016\/j.ocl.2023.02.005_bib57","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ocl.2023.02.005_bib59","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2337\/dc20-0437","article-title":"Effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: post hoc analyses of the LEADER trial","volume":"43","author":"Crowley","year":"2020","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ocl.2023.02.005_bib60","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00125-022-05715-4","article-title":"Management of type 2 diabetes with the dual GIP\/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis","volume":"65","author":"Karagiannis","year":"2022","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ocl.2023.02.005_bib62","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ocl.2023.02.005_bib63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ocl.2023.02.005_bib64","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"author":"Ingelheim","key":"10.1016\/j.ocl.2023.02.005_bib65"},{"author":"Janssen","key":"10.1016\/j.ocl.2023.02.005_bib66"},{"issue":"9","key":"10.1016\/j.ocl.2023.02.005_bib68","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamainternmed.2018.3034","article-title":"Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes","volume":"178","author":"Chang","year":"2018","journal-title":"JAMA Intern Med"},{"year":"2020","series-title":"Prescribing information for INVOKANA. Beerse, Belgium","author":"Janssen","key":"10.1016\/j.ocl.2023.02.005_bib69"},{"issue":"12","key":"10.1016\/j.ocl.2023.02.005_bib70","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s00198-020-05590-y","article-title":"Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials","volume":"31","author":"Qian","year":"2020","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.ocl.2023.02.005_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40618-019-01103-9","article-title":"Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis","volume":"43","author":"Dorsey-Trevi\u00f1o","year":"2020","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib72","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/dom.14671","article-title":"Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial","volume":"24","author":"Barraclough","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib73","first-page":"S111","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib74","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc22-S012","article-title":"12. Retinopathy, Neuropathy, and Foot care: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib75","doi-asserted-by":"crossref","first-page":"e3269","DOI":"10.1002\/dmrr.3269","article-title":"Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Bus","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"14","key":"10.1016\/j.ocl.2023.02.005_bib76","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ocl.2023.02.005_bib77","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00125-021-05397-4","article-title":"Realising the long-term promise of insulin therapy: the DCCT\/EDIC study","volume":"64","author":"Nathan","year":"2021","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.ocl.2023.02.005_bib78","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.2337\/dc20-3097","article-title":"Understanding metabolic memory: the prolonged influence of glycemia during the Diabetes Control and Complications Trial (DCCT) on future risks of complications during the study of the Epidemiologyof Diabetes Interventions and Complications (EDIC)","volume":"44","author":"Lachin","year":"2021","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.ocl.2023.02.005_bib79","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9131","key":"10.1016\/j.ocl.2023.02.005_bib80","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"7160","key":"10.1016\/j.ocl.2023.02.005_bib81","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group","volume":"317","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ocl.2023.02.005_bib82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/dc21-1816","article-title":"Risk of foot ulcer and lower-extremity amputation among participants in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"45","author":"Boyko","year":"2022","journal-title":"Diabetes Care"},{"issue":"2 Suppl","key":"10.1016\/j.ocl.2023.02.005_bib83","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2015.10.003","article-title":"The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine","volume":"63","author":"Hingorani","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ocl.2023.02.005_bib84","doi-asserted-by":"crossref","first-page":"29758","DOI":"10.3402\/dfa.v7.29758","article-title":"Type 2 diabetes-related foot care knowledge and foot self-care practice interventions in the United States: a systematic review of the literature","volume":"7","author":"Bonner","year":"2016","journal-title":"Diabet Foot Ankle"},{"issue":"12","key":"10.1016\/j.ocl.2023.02.005_bib85","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ocl.2023.02.005_bib86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1071100715611951","article-title":"Preventive and therapeutic strategies for diabetic foot ulcers","volume":"37","author":"Cychosz","year":"2016","journal-title":"Foot Ankle Int"},{"issue":"7","key":"10.1016\/j.ocl.2023.02.005_bib87","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.ASW.0000450831.65667.89","article-title":"Diabetic foot ulcer off-loading: the gap between evidence and practice. Data from the US Wound Registry","volume":"27","author":"Fife","year":"2014","journal-title":"Adv Skin Wound Care"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib88","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/iwj.12213","article-title":"Randomised clinical trial to compare total contact casts, healing sandals and a shear-reducing removable boot to heal diabetic foot ulcers","volume":"12","author":"Lavery","year":"2015","journal-title":"Int Wound J"},{"issue":"6","key":"10.1016\/j.ocl.2023.02.005_bib89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ejvs.2014.03.005","article-title":"Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review","volume":"47","author":"Stoekenbroek","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"10.1016\/j.ocl.2023.02.005_bib90","first-page":"18","article-title":"A\u00a0prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer","volume":"59","author":"Ma","year":"2013","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.ocl.2023.02.005_bib91","first-page":"CD010318","article-title":"Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus","volume":"10","author":"Dumville","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"year":"2014","series-title":"Negative pressure wound therapy technologies for chronic wound care in the home setting","author":"Rhee","key":"10.1016\/j.ocl.2023.02.005_bib92"},{"issue":"Suppl 1","key":"10.1016\/j.ocl.2023.02.005_bib93","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/dmrr.2249","article-title":"A\u00a0systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease","volume":"28","author":"Hinchliffe","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.ocl.2023.02.005_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"issue":"4","key":"10.1016\/j.ocl.2023.02.005_bib95","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ocl.2023.02.005_bib96","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with Ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Orthopedic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589823000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589823000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:49:20Z","timestamp":1758466160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030589823000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0030589823000330"],"URL":"https:\/\/doi.org\/10.1016\/j.ocl.2023.02.005","relation":{},"ISSN":["0030-5898"],"issn-type":[{"type":"print","value":"0030-5898"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Medical Management of Diabetes","name":"articletitle","label":"Article Title"},{"value":"Orthopedic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ocl.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}